Childhood-Onset ANCA-Associated Vasculitis: From Genetic Studies to Advances in Pathogenesis, Classification and Novel Therapeutic Approaches
International Journal of Molecular Sciences · 22.12.2024 · 25 (24) · 13704
DOI: 10.3390/ijms252413704 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 22.12.2024. Verfasst von Liching Yeo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, Homerton University Hospital, London E9 6SR, UK. Hauptthemen laut MEDLINE: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Age of Onset. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Health Research (NIHR) University College London Hospital (UCLH) Biomedical Research Centre, Centre for Adolescent Rheumatology Versus Arthritis at University College London (UCL), UCLH, and Great Ormond Street Hospital (GOSH) and supported by Versus A…, Great Ormond Street Children’s Charity.
Abstract (Originalsprache)
Childhood-onset antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) represents a heterogeneous group of multi-system autoimmune conditions associated with chronic inflammation, characteristically affecting small blood vessels, leading to various organ and system manifestations. Although rare in paediatric populations, AAV poses challenges in early recognition, diagnosis and management of refractory cases. This review highlights the characteristics of clinical presentation and outcomes of AAV in children, as well as its current classification and progress achieved in understanding the disease pathogenesis, with a focus on adult and paediatric genetic studies. Furthermore, we discuss the management of AAV in children, as well as new emerging therapies and future research needs, while proposing a potential algorithm for a childhood-onset-AAV therapeutic approach based on the disease phenotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Paediatrics, Homerton University Hospital, London E9 6SR, UK.
- Department of Paediatric Rheumatology, Great Ormond Street Hospital, London WC1N 3JH, UK.
- Department of Paediatrics, Southend University Hospital, Westcliff-on-Sea SS0 0RY, UK.
- Department of Adolescent and Young Adult Rheumatology, University College London NHS Foundation Trust, London NW1 2PG, UK.
- Centre for Adolescent Rheumatology, Division of Medicine, University College London, Rayne Building, London WC1E 6JF, UK.
ORCID-Profile: Coziana Ciurtin
Förderung
- National Institute of Health Research (NIHR) University College London Hospital (UCLH) Biomedical Research Centre
- Centre for Adolescent Rheumatology Versus Arthritis at University College London (UCL), UCLH, and Great Ormond Street Hospital (GOSH) and supported by Versus A…
- Great Ormond Street Children’s Charity
- NIHR-Biomedical Research Centres at both GOSH and UCLH
Zitieren
APA
Yeo, L., Naheed, A., Richards, C., & Ciurtin, C. (2024). Childhood-Onset ANCA-Associated Vasculitis: From Genetic Studies to Advances in Pathogenesis, Classification and Novel Therapeutic Approaches. International Journal of Molecular Sciences, 25(24), 13704. https://doi.org/10.3390/ijms252413704
Vancouver
Yeo L, Naheed A, Richards C, Ciurtin C. Childhood-Onset ANCA-Associated Vasculitis: From Genetic Studies to Advances in Pathogenesis, Classification and Novel Therapeutic Approaches. International Journal of Molecular Sciences. 2024;25(24):13704. doi:10.3390/ijms252413704
BibTeX
@article{Yeo2024,
author = {Yeo, Liching and Naheed, Asma and Richards, Chantelle and Ciurtin, Coziana},
title = {Childhood-Onset ANCA-Associated Vasculitis: From Genetic Studies to Advances in Pathogenesis, Classification and Novel Therapeutic Approaches},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {24},
pages = {13704},
doi = {10.3390/ijms252413704}
}
EUVIMED